Malabsorption Syndromes

• Luminal Phase Dysfunction: Digestion of macronutrients begins in the stomach and duodenum, where pancreatic enzymes (amylase, proteases, lipase) and bile salts emulsify and break down food into absorbable units. In pancreatic insufficiency, deficient enzyme secretion results in incomplete hydrolysis of triglycerides to monoglycerides and fatty acids, and proteins to amino acids and dipeptides. This is most evident with lipase deficiency, producing steatorrhea (>7 g fecal fat daily, often >100 g in severe cases). Similarly, bile acid insufficiency—whether from cholestasis, ileal disease, or bacterial overgrowth—impairs fat emulsification and micelle formation. Micelles are crucial amphipathic structures containing fatty acids, monoglycerides, and fat-soluble vitamins (A, D, E, K); without adequate bile salts, these lipophilic molecules cannot be transported to the mucosa.

• Mucosal Phase Dysfunction: The intestinal epithelium must possess sufficient absorptive surface area and intact enterocytes with appropriate transporters. Celiac disease triggers gluten-dependent immune destruction of intestinal villi, reducing surface area by up to 90% and damaging brush border enzymes (lactase, sucrase-isomaltase). Tissue transglutaminase (tTG) cross-links deamidated gluten peptides, which are recognized by HLA-DQ2 or HLA-DQ8 molecules, activating intraepithelial lymphocytes and lamina propria T cells. In tropical sprue, mucosal inflammation and villous blunting occur without specific autoimmunity; nutritional deficiencies (particularly folate) perpetuate mucosal damage. Whipple's disease (caused by Tropheryma whipplei) produces foamy macrophage infiltration of lamina propria, physically disrupting absorption and systemic dissemination. Crohn's disease causes transmural inflammation, fissuring ulcers, and strictures that reduce functional surface area. In short bowel syndrome, insufficient remaining small intestine (<200 cm) cannot absorb adequate nutrients; however, adaptive hyperplasia and increased intestinal transit time over months can improve absorption in some patients. Primary lactase deficiency reflects age-related decline in brush border lactase, producing osmotic diarrhea when lactose is not hydrolyzed; this is especially prevalent in Asian and African populations due to genetic factors.

• Post-Mucosal (Transport) Phase Dysfunction: Following absorption, nutrients must be packaged and transported. Abetalipoproteinemia results from mutations in APOB gene, preventing synthesis of apolipoprotein B (essential for chylomicron and VLDL formation). Fat-soluble vitamins accumulate in enterocytes but cannot be secreted, leading to profound deficiency of vitamins A, D, E, and K. Vitamin E deficiency causes neurologic manifestations (ataxia, ophthalmoplegia) that are potentially reversible if treated early. Lymphangiectasia (congenital or secondary to obstruction/inflammation) impairs lymphatic drainage of chylomicrons, producing protein and fat malabsorption with characteristic low serum albumin and lymphocytopenia.

• Motility Dysfunction: Normal intestinal motility ensures adequate contact between nutrients and mucosa; prolonged transit allows more complete absorption, while accelerated transit limits it. Small intestinal bacterial overgrowth (SIBO) occurs when stasis permits colonic bacteria to colonize the small intestine (>10⁵ CFU/mL). These bacteria metabolize carbohydrates to hydrogen and methane (detected on breath testing), producing osmotic diarrhea and bloating; they also deconjugate bile salts, impairing fat absorption. Scleroderma produces patchy fibrosis and dysmotility of the small intestine, predisposing to SIBO.

• Mucosal Disorders (Most Common):
• Celiac disease (celiac sprue): Autoimmune enteropathy triggered by gluten (prolamin found in wheat, barley, rye). HLA-DQ2 (95%) or HLA-DQ8 (5%) association is pathognomonic; negative serology has >95% negative predictive value, making it excellent for screening. Associated with dermatitis herpetiformis, osteoporosis, iron deficiency anemia, and increased risk of small bowel lymphoma if untreated.
• Non-celiac gluten sensitivity: Clinical symptoms and improved absorption off gluten without celiac or wheat allergy serology; diagnosis is clinical and by exclusion.
• Tropical sprue: Endemic in Caribbean and South and Southeast Asia; etiology unclear but possibly infectious (spirochetes suspected). Villous blunting and inflammation improve with prolonged antibiotic therapy (tetracycline) and B vitamins.
• Whipple's disease: Rare systemic infection with gram-positive Tropheryma whipplei; predominantly affects white men aged 30–60; classic triad of arthralgias, fever, and diarrhea with weight loss. CNS involvement (dementia, ophthalmoplegia) and relapsing infection are serious complications if untreated.
• Crohn's disease: Transmural inflammation of any GI segment; small bowel involvement causes malabsorption via reduced surface area, inflammation, and structuring. Associated with extraintestinal manifestations (arthritis, uveitis, erythema nodosum).
• Ulcerative colitis: Colonic inflammation; malabsorption is less prominent than in Crohn's but water and electrolyte losses are significant.
• Short bowel syndrome: Results from extensive resection (>200 cm loss) for Crohn's, ischemia, trauma, or malignancy. Severity depends on length remaining, site (terminal ileum loss is most problematic due to specialized B₁₂ and bile salt absorption), and presence of ileocecal valve.
• Primary lymphangiectasia: Congenital dilated lymphatics; hypoplastic vessels impair chylomicron drainage. Presents in infancy with protein-losing enteropathy (hypoalbuminemia, hypogammaglobulinemia).
• Secondary lymphangiectasia: Occurs with lymphatic obstruction from malignancy, TB, sarcoidosis, or Crohn's disease.
• Tropical enteropathy: Subclinical mucosal blunting seen in populations in resource-limited areas; reversible with improved sanitation and nutrition.

• Pancreatic Disorders:
• Chronic pancreatitis: Progressive parenchymal destruction from alcohol abuse (most common in Western countries), cystic fibrosis, autoimmune pancreatitis, or hemochromatosis. Steatorrhea typically emerges when pancreatic lipase secretion falls below 10% of normal. Characterized by pancreatic calcifications on imaging and elevated fecal elastase-1 (>200 μg/g is normal, <200 μg/g suggests insufficiency).
• Cystic fibrosis: Autosomal recessive CFTR gene mutation preventing chloride channel function; thick secretions obstruct pancreatic ducts, causing acinar atrophy and fibrosis. Malabsorption is often the presenting feature in infants (meconium ileus, failure to thrive). Pancreatic insufficiency is virtually universal by adulthood; screening via immunoreactive trypsinogen in newborns is standard.
• Pancreatic cancer: Obstruction of pancreatic duct or sphincter of Oddi may cause steatorrhea; usually associated with jaundice and weight loss in advanced disease.
• Post-surgical: Gastrectomy (reduced gastric acid and intrinsic factor), bilioenteric bypass, or pancreatectomy.

• Biliary and Hepatic Disorders:
• Cholestasis (primary biliary cholangitis [PBC], primary sclerosing cholangitis [PSC], drug-induced): Reduced bile acid secretion impairs micelle formation and fat-soluble vitamin absorption.
• Biliary obstruction: Stones, strictures, or malignancy preventing bile entry into duodenum.
• Bacterial overgrowth of bile salts: Leads to deconjugation and increased bacterial metabolism of fats.
• Ileal disease or resection: Impairs reabsorption of bile acids in terminal ileum; bile acid pool becomes depleted, exacerbating steatorrhea (>20 g daily in severe disease).

• Motility Disorders:
• SIBO: Associated with achlorhydria, blind loops, strictures, diverticula, scleroderma, diabetes mellitus, and irritable bowel syndrome. Hydrogen or methane on breath testing (>20 ppm increase within 90 minutes diagnostic) is the gold standard for diagnosis.
• Gastroparesis: Impaired gastric emptying delays nutrient delivery to small intestine.
• Scleroderma: Widespread smooth muscle fibrosis and dysmotility predispose to SIBO.
• Pseudo-obstruction: Idiopathic or secondary to amyloidosis, diabetes, or medications (opioids, anticholinergics).

• Nutrient-Specific Malabsorption:
• Vitamin B₁₂ deficiency: Pernicious anemia (autoimmune gastritis with intrinsic factor antibodies), terminal ileum disease (Crohn's, TB, tropical sprue), or gastrectomy. Diphyllobothrium latum (fish tapeworm) competes for B₁₂.
• Iron deficiency: Celiac disease, H. pylori, PPIs (reduce acid-dependent absorption), and post-gastrectomy states.
• Lactose intolerance: Primary (genetically determined decline in lactase, affecting ~65% of humans after weaning) or secondary (mucosal damage in celiac, tropical sprue, Crohn's).
• Calcium and vitamin D malabsorption: Occurs in pancreatic insufficiency (impaired micelle formation) and small intestinal disease; leads to secondary hyperparathyroidism and osteoporosis.

• Genetic/Congenital Disorders:
• Abetalipoproteinemia: Recessive APOB mutations; near-total absence of apolipoprotein B prevents chylomicron assembly. Severe fat-soluble vitamin deficiency and progressive neurologic disease (ataxia, retinitis pigmentosa) develop without treatment.
• Familial hypocholesterolemia type II: Not strictly malabsorption but impairs absorption of some lipophilic compounds.

• Steatorrhea (fatty stools): Hallmark finding resulting from malabsorbed fat (>7 g daily on 100 g dietary fat). Stools are pale, voluminous, greasy, and float due to increased gas content; they may have an offensive odor from bacterial fermentation. Presence confirms fat malabsorption and narrows diagnosis to pancreatic, biliary, or mucosal etiologies; notably, small bowel bacterial overgrowth may produce diarrhea without steatorrhea (carbohydrate malabsorption instead).

• Diarrhea: Osmotic diarrhea (occurs with fasting, ceases overnight) is characteristic of carbohydrate malabsorption (lactose intolerance, SIBO) and results from unabsorbed solutes drawing water into the lumen. Secretory diarrhea (persists with fasting, large volume >1 L/day) suggests active mucosal inflammation, bacterial toxins, or hormonal stimulation (as in Zollinger-Ellison syndrome complicating pancreatic insufficiency). Mixed patterns are common (e.g., celiac disease produces both osmotic and secretory components).

• Weight loss and failure to thrive: Reflects caloric malabsorption; in infants and children, this is the most concerning manifestation and may be the sole initial sign (e.g., cystic fibrosis presenting as failure to thrive at 2–3 months). Progressive weight loss despite adequate oral intake is a cardinal feature distinguishing malabsorption from inadequate caloric intake.

• Bloating, abdominal distension, and flatulence: Result from bacterial fermentation of unabsorbed carbohydrates and fats, producing H₂ and CH₄ gas. In SIBO, these symptoms are exaggerated and associated with visible abdominal distension that worsens throughout the day.

• Protein malabsorption manifestations:
• Hypoalbuminemia and edema: Protein-losing enteropathy (exudation of albumin into GI lumen) occurs with intestinal lymphangiectasia, Crohn's disease with severe ulceration, and Whipple's disease. Serum albumin <2.5 g/dL indicates severe protein loss and predicts complications (impaired wound healing, infection, ascites).
• Hair and nail changes: Sparse, brittle, depigmented hair and horizontal ridging of nails reflect protein-energy malnutrition; "flag sign" (transverse band of depigmented hair) may be seen in severe kwashiorkor-like states.

• Anemia and bleeding manifestations:
• Iron deficiency anemia: Celiac disease is the most common cause of refractory iron deficiency in the US; mechanism includes reduced acid-dependent Fe²⁺ absorption in proximal duodenum (which is damaged in celiac) and ongoing GI blood loss from mucosal ulceration.
• Megaloblastic anemia: Results from B₁₂ or folate deficiency; B₁₂ deficiency (pernicious anemia, terminal ileum disease) develops insidiously over years due to hepatic stores (~2 kg total). Folate deficiency (tropical sprue, cystic fibrosis) manifests more acutely (2–3 months) due to minimal tissue stores. Macrocytosis (MCV >100 fL) and hypersegmented neutrophils on smear are characteristic.
• Easy bruising, bleeding gums, poor wound healing: Indicate vitamin K deficiency (malabsorbed as fat-soluble vitamin); coagulopathy with elevated PT/INR is reversible with parenteral phylloquinone (vitamin K1).

• Bone disease manifestations:
• Bone pain, fractures, and growth retardation: Result from vitamin D and calcium malabsorption. In pancreatic insufficiency, calcium is precipitated by fatty acids in the intestinal lumen, reducing its bioavailability. Secondary hyperparathyroidism develops (PTH elevated, calcium low-normal to low, phosphate low). Osteoporosis and osteomalacia are common in celiac disease and cystic fibrosis, detected on DEXA scan or biochemical markers (alkaline phosphatase, 25-hydroxyvitamin D <20 ng/mL).
• Tetany and paresthesias: Indicate severe hypocalcemia (calcium <6.5 mg/dL) from concurrent vitamin D deficiency; Chvostek's sign (twitching of mouth with facial nerve percussion) and Tro

Step 1 — confirm malabsorption

• **Qualitative fecal fat (Sudan III stain)**: cheap screening test; stains unabsorbed triglyceride droplets. Positive result prompts quantification.
• 72-hour quantitative fecal fat: historical gold standard for steatorrhea while on a defined ~100 g/day fat diet; excretion above ~7 g/day is abnormal, and massive values point toward pancreatic or bile-salt causes.
• Stool electrolytes and osmotic gap: a wide gap (calculated as 290 − 2×[stool Na + K]) indicates osmotic/malabsorptive diarrhea; a narrow gap suggests a secretory process.

Step 2 — localize the defect

• D-xylose absorption test: xylose is absorbed passively by proximal jejunal mucosa without needing pancreatic enzymes or bile. Low urinary/serum xylose = mucosal disease (celiac, tropical sprue, Whipple); normal xylose with steatorrhea = pancreatic insufficiency. Falsely low in SIBO (luminal bacteria consume xylose — corrects after antibiotics) and in renal failure or delayed gastric emptying.
• Fecal elastase-1: low values indicate exocrine pancreatic insufficiency; the ACG chronic pancreatitis guideline endorses it as the practical first-line test, with cross-sectional imaging (CT/MRCP, or EUS) for ductal changes and calcifications.
• Glucose or lactulose hydrogen/methane breath testing: an early rise in breath hydrogen supports SIBO per the ACG guideline; a positive lactose breath test with symptom reproduction confirms lactase deficiency.

Step 3 — establish the specific diagnosis

• Celiac serology: IgA tissue transglutaminase with a simultaneous total IgA (ACG celiac guideline), obtained while the patient is still eating gluten. Anti-endomysial IgA is the most specific confirmatory serology; deamidated gliadin peptide IgG is used when IgA-deficient.
• Duodenal biopsy (bulb plus distal duodenum) remains confirmatory in adults, graded by the Marsh–Oberhuber classification: intraepithelial lymphocytosis → crypt hyperplasia → partial to total villous atrophy. ESPGHAN permits a no-biopsy pathway in selected children with very high tTG titers plus positive EMA.
• Targeted biopsy findings: PAS-positive, diastase-resistant foamy macrophages in Whipple disease (confirm with T. whipplei PCR); absent villous fat-laden enterocytes with acanthocytes on smear in abetalipoproteinemia; dilated lacteals in lymphangiectasia.
• HLA-DQ2/DQ8 testing has value only for its negative predictive value (excludes celiac).

Immediate stabilization

• Volume and electrolyte repletion: isotonic crystalloid with correction of hypokalemia, hypomagnesemia, and hypocalcemia; magnesium must be replaced before hypocalcemia will correct, since hypomagnesemia impairs PTH release and action.
• Parenteral vitamin K (phytonadione) for malabsorption-related coagulopathy with a prolonged INR — oral repletion is unreliable when fat absorption is impaired.
• Thiamine before glucose-containing fluids or feeds, and phosphate monitoring, to prevent Wernicke encephalopathy and refeeding syndrome in the severely depleted patient.

Etiology-directed first-line therapy

• Lifelong strict gluten-free diet with dietitian involvement is the only proven treatment for celiac disease (ACG celiac guideline); serology and symptoms are followed to gauge adherence. Do not start the diet before serology and biopsy — it invalidates testing.
• Pancreatic enzyme replacement therapy (PERT): enteric-coated lipase-containing preparations (pancrelipase) with every meal and snack, dosed in lipase units, per the ACG chronic pancreatitis guideline and Cystic Fibrosis Foundation recommendations. A proton pump inhibitor is added when response is inadequate, because gastric acid inactivates lipase and prevents enteric coating dissolution.
• Antibiotics: rifaximin (nonabsorbed) for SIBO; tetracycline/doxycycline plus folate for tropical sprue; for Whipple disease, IV ceftriaxone (or penicillin) induction followed by prolonged oral trimethoprim-sulfamethoxazole to eradicate CNS reservoirs.
• Nutrient-specific replacement: parenteral B₁₂ for terminal ileal disease or pernicious anemia, iron, folate, zinc, and fat-soluble vitamins A/D/E/K in water-miscible forms.
• Lactase supplementation and lactose restriction for lactase deficiency; dapsone for dermatitis herpetiformis alongside the gluten-free diet.
• Medium-chain triglyceride (MCT)-based diet: MCTs are absorbed directly into portal blood without micelles or chylomicrons — the cornerstone of therapy in intestinal lymphangiectasia and abetalipoproteinemia (with very high-dose vitamin E).

Escalation and definitive management

• Bile-acid binders (cholestyramine) for bile-acid diarrhea after limited ileal resection; conversely, extensive resection causes bile-acid depletion and binders worsen steatorrhea.
• Short bowel syndrome: parenteral nutrition, antisecretory therapy, and the GLP-2 analog teduglutide to promote mucosal adaptation; intestinal transplantation is reserved for irreversible intestinal failure with PN complications.
• Refractory celiac disease: budesonide or systemic corticosteroids after excluding gluten contamination and lymphoma.
• Surgery is directed at the underlying lesion (stricturoplasty/resection in Crohn's, biliary decompression, blind-loop takedown).

Emergencies

• Refeeding syndrome: reintroduction of carbohydrate drives an insulin surge that shifts phosphate, potassium, and magnesium intracellularly; profound hypophosphatemia causes arrhythmia, rhabdomyolysis, and respiratory failure. Signalled by falling phosphate within days of nutritional repletion — advance calories slowly and replete thiamine.
• Hypocalcemic tetany and laryngospasm: vitamin D/calcium malabsorption with coexisting hypomagnesemia; Chvostek and Trousseau signs, prolonged QT.
• Vitamin K–dependent coagulopathy: elevated PT/INR with normal platelets; intracranial or GI hemorrhage is the feared event.
• Celiac crisis: rare fulminant diarrhea with dehydration, metabolic acidosis, and electrolyte collapse requiring ICU-level care.
• Post-splenectomy-type sepsis physiology: functional hyposplenism accompanies celiac disease; Howell-Jolly bodies on smear should prompt pneumococcal, meningococcal, and Hib vaccination.

Chronic disease complications

• Enteropathy-associated T-cell lymphoma and small bowel adenocarcinoma: suggested by return of symptoms, weight loss, or abdominal pain after a period of good response to a gluten-free diet — the classic stem for refractory celiac disease type II.
• Metabolic bone disease: osteomalacia and osteoporosis from vitamin D and calcium malabsorption with secondary hyperparathyroidism; low-trauma fracture is the presenting event.
• Enteric hyperoxaluria and calcium oxalate stones: unabsorbed fatty acids bind luminal calcium, leaving oxalate free for colonic absorption — seen in fat malabsorption and short bowel with intact colon.
• Cholesterol gallstones: ileal bile-acid loss depletes the bile-acid pool and supersaturates bile.
• Neurologic deficits: vitamin E deficiency causes spinocerebellar ataxia and loss of proprioception (prominent in abetalipoproteinemia); B₁₂ deficiency produces subacute combined degeneration; vitamin A deficiency causes night blindness and Bitot spots.
• Whipple disease relapse with CNS involvement: oculomasticatory myorhythmia and dementia; regimens must include CNS-penetrant therapy.

Treatment-related

• Fibrosing colonopathy from very high-dose pancreatic enzyme preparations, classically in children with cystic fibrosis — presents as colonic stricture and obstruction.
• Parenteral nutrition complications: catheter-related bloodstream infection, venous thrombosis, and intestinal failure–associated liver disease with rising conjugated bilirubin.
• D-lactic acidosis in short bowel syndrome: colonic bacterial fermentation of malabsorbed carbohydrate produces D-lactate — anion gap acidosis with encephalopathy and a normal standard lactate assay.
• Immune reconstitution inflammatory syndrome after starting Whipple therapy, especially in previously immunosuppressed patients.

• D-xylose is the localizing test: normal urinary xylose with steatorrhea points to pancreatic insufficiency; low xylose points to mucosal disease. A low value that normalizes after antibiotics means SIBO, not celiac disease — this is the classic distractor.
• Best next step in suspected celiac disease: IgA tissue transglutaminase plus total IgA, drawn while the patient is still consuming gluten, followed by duodenal biopsy in adults. If the stem says the patient already started a gluten-free diet, the answer is gluten challenge or HLA-DQ2/DQ8 testing — not immediate serology.
• Refractory iron deficiency anemia in a young adult unresponsive to oral iron is celiac disease until proven otherwise; duodenal involvement destroys the primary site of iron absorption.
• Buzzword mapping: PAS-positive foamy macrophages → Whipple disease; dermatitis herpetiformis with granular IgA at the dermal papillae → celiac disease (treat with dapsone plus gluten-free diet); acanthocytes with absent chylomicrons and retinitis pigmentosa → abetalipoproteinemia; pancreatic calcifications with normal D-xylose → chronic pancreatitis.
• Marsh classification grades celiac histology from intraepithelial lymphocytosis to total villous atrophy — know the direction, not the numbers.
• Terminal ileum is special: it alone absorbs B₁₂-intrinsic factor complex and conjugated bile acids. Limited resection → bile-acid diarrhea (treat with cholestyramine); extensive resection → bile-acid depletion and steatorrhea (cholestyramine makes it worse). This reversal is a favorite trap.
• Fat-soluble vitamin deficiencies travel together (A, D, E, K) whenever micelle formation fails; a prolonged INR that corrects with parenteral vitamin K distinguishes malabsorption from hepatocellular failure.
• New symptoms after years of successful gluten-free diet = dietary contamination, refractory celiac disease, or enteropathy-associated T-cell lymphoma — the single association examiners test most.
• MCTs bypass the micelle and chylomicron pathway, entering portal blood directly; that is why they are used in lymphangiectasia and abetalipoproteinemia.